HSBC Holdings
LXRX icon

HSBC Holdings’s Lexicon Pharmaceuticals LXRX Stock Holding History

HSBC Holdings’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,415
Closed -$7.76K – 3149
2025
Q1 		$7.76K Sell
13,415
-87
-0.6% -$55 ﹤0.01% 2994
2024
Q4 		$9.65K Buy
+13,502
New +$16.3K ﹤0.01% 3071
2017
Q1 		– Sell
-10,365
Closed -$144K – 2383
2016
Q4 		$144K Buy
+10,365
New +$166K ﹤0.01% 2585
2015
Q2 		– Sell
-4,712
Closed -$31K – 2198
2015
Q1 		$31K Buy
4,712
+870
+23% +$5.94K ﹤0.01% 2025
2014
Q4 		$24K Buy
+3,842
New +$31K ﹤0.01% 1770

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.26B AUM 47.23% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return